Tuberculosis screening in a novel substance abuse treatment center in Malaysia: implications for a comprehensive approach for integrated care
- PMID: 24074846
- PMCID: PMC5189907
- DOI: 10.1016/j.jsat.2013.08.023
Tuberculosis screening in a novel substance abuse treatment center in Malaysia: implications for a comprehensive approach for integrated care
Abstract
People who use drugs (PWUD) represent a key high risk group for tuberculosis (TB). The prevalence of both latent TB infection (LTBI) and active disease in drug treatment centers in Malaysia is unknown. A cross-sectional convenience survey was conducted to assess the prevalence and correlates of LTBI among attendees at a recently created voluntary drug treatment center using a standardized questionnaire and tuberculin skin testing (TST). Participants (N=196) were mostly men (95%), under 40 (median age=36 years) and reported heroin use immediately before treatment entry (75%). Positive TST prevalence was 86.7%. Nine (4.6%) participants were HIV-infected. Previous arrest/incarcerations (AOR=1.1 for every entry, p<0.05) and not being HIV-infected (AOR=6.04, p=0.03) were significantly associated with TST positivity. There is an urgent need to establish TB screening and treatment programs in substance abuse treatment centers and to tailor service delivery to the complex treatment needs of patients with multiple medical and psychiatric co-morbidities.
Keywords: HIV; Integration; Malaysia; Substance use; Tuberculosis.
© 2013.
Conflict of interest statement
☆ Conflict of interest: None declared.
Figures
References
-
- Al-Darraji HA, Kamarulzaman A, Altice FL. High Prevalence of TB/HIV Co-infection in a Malaysian Prison. Paper presented at the 42nd World Conference on Lung Health of the International Union Against Tuberculosis and Lung Disease. Poster Presentation (PC-944-28); Lille, France. 2011.
-
- Al-Darraji HA, Kamarulzaman A, Altice FL. Isoniazid preventive therapy in correctional facilities: A systematic review. The International Journal of Tuberculosis and Lung Disease. 2012;16:871–879. - PubMed
-
- Altice FL, Bruce RD, Lucas GM, Lum PJ, Korthuis PT, Flanigan TP, et al. HIV treatment outcomes among HIV-infected, opioid-dependent patients receiving buprenorphine/naloxone treatment within HIV clinical care settings: Results from a multisite study. Journal of Acquired Immune Deficiency Syndromes. 2011;56(Suppl 1):S22–S32. - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
